An important step forward for biosimilars in cancer treatment Journal Article
| Authors: | Schleicher, S. M.; Seidman, A. D. |
| Article Title: | An important step forward for biosimilars in cancer treatment |
| Keywords: | adult; controlled study; major clinical study; overall survival; neutropenia; cancer growth; diarrhea; drug efficacy; drug safety; note; progression free survival; randomized controlled trial; peripheral neuropathy; antineoplastic activity; drug potency; multicenter study; phase 3 clinical trial; taxane derivative; trastuzumab; double blind procedure; metastatic breast cancer; human epidermal growth factor receptor 2 positive breast cancer; human; female; biosimilar agent; european medicines agency |
| Journal Title: | JAMA Oncology |
| Volume: | 3 |
| Issue: | 7 |
| ISSN: | 2374-2437 |
| Publisher: | American Medical Association |
| Date Published: | 2017-07-01 |
| Start Page: | 989 |
| End Page: | 990 |
| Language: | English |
| DOI: | 10.1001/jamaoncol.2016.6789 |
| PROVIDER: | scopus |
| PUBMED: | 28196209 |
| DOI/URL: | |
| Notes: | Note -- Export Date: 2 January 2018 -- Source: Scopus |
